 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Overall, the index has still been in the range with 19,750-19,800 likely to act as a crucial resistance as breaking of the same can drive the Nifty50 towards 20,000 mark, whereas 19,500 is expected to be immediate support and 19,200 may be crucial support for the index, experts said

Ten best bets for Oct series as bulls may charge when Nifty holds 19,800

CMS Info Systems shares fell more than 7 percent to Rs 363 on the NSE.

Bulk deals | Promoter Sion Investment Holdings sells 19.43% stake in CMS Info Systems

CA Alchemy had held 20 percent stake or 23.86 crore equity shares in Piramal Pharma as of June 2023.

Bulk Deals: PHI Capital Trust exits Minda Corporation, Carlyle Group offloads 2.17% stake in Piramal Pharma

Motilal Oswal is bullish on Piramal Pharma recommended buy rating on the stock with a target price of Rs 125 in its research report dated August 04, 2023.

Buy Piramal Pharma; target of Rs 125: Motilal Oswal

EBITDA margin for the June quarter grew to 10 percent up from 6 percent in Q1FY23.

Piramal Pharma trades lower by over 2% after Q1 earnings

Piramal Pharma Consolidated June 2023 Net Sales at Rs 1,748.85 crore, up 18.01% Y-o-Y

Piramal Pharma Standalone June 2023 Net Sales at Rs 846.43 crore, up 13.39% Y-o-Y

The record date for determining the shareholders eligible for the rights issue is August 2. The issue will close on August 16

Piramal Pharma rights issue at Rs 81 a share, opens August 8

The pharma firm, which filed draft papers with the regulator in March, obtained its observation letter on July 12, an update with the Securities and Exchange Board of India (Sebi) showed on Tuesday.

Piramal Pharma's Rs 1,050 crore rights issue gets Sebi's nod

LED lighting solutions manufacturer IKIO Lighting had a stellar debut on the bourses, rising 41.7 percent to settle at Rs 403.75.

Bulk Deals: Quant MF buys 2.15% in IKIO Lighting, Canada-based pension fund sells nearly Rs 100 crore shares in Piramal Pharma

Piramal Pharma Ltd. engages in development and manufacturing of pharmaceutical products. It offers skin care, vitamins and nutrition, antacids, analgesics, gastro-intestinal, and baby-care. The company was founded on March 4, 20202 and is headquartered in Mumbai, India.

Watchers	119
52-Wk Low	63.10
52-Wk High	200.00

Market Cap	124.69B
Volume (M)	1.23M
52-Wk High	200.00
52-Wk Low	63.10

PPLPHARMA.NSE Piramal Pharma Limited

About

Feed

News

Sentiment

Fundamentals